These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11874406)

  • 21. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types.
    Corbetta S; Pizzocaro A; Peracchi M; Beck-Peccoz P; Faglia G; Spada A
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):507-12. PubMed ID: 9425388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risks of overlooking the diagnosis of secreting pituitary adenomas.
    Brue T; Castinetti F
    Orphanet J Rare Dis; 2016 Oct; 11(1):135. PubMed ID: 27716353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between expression of vascular endothelial growth factor and the proliferation of prolactinomas.
    Li N; Jiang Z
    Clin Neurol Neurosurg; 2017 Feb; 153():102-106. PubMed ID: 28110235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.
    Warnet A; Porsova-Dutoit I; Lahlou N; Seret-Begue D; Lajeunie E; Chanson P; Woimant F; Lot G; Guillausseau PJ; Roger M
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):177-84. PubMed ID: 7523001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GHRH plus arginine in the diagnosis of acquired GH deficiency of childhood-onset.
    Maghnie M; Cavigioli F; Tinelli C; Autelli M; Aricò M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2740-4. PubMed ID: 12050243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone status following treatment for Cushing's syndrome.
    Hughes NR; Lissett CA; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas.
    Nishioka H; Haraoka J
    Acta Neuropathol; 2005 Jun; 109(6):598-602. PubMed ID: 15895198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of growth hormone, prolactin and human beta-chorionic gonadotropin mRNA in growth hormone-secreting pituitary adenomas and in prolactin-secreting pituitary adenomas by in situ hybridization using a non-isotopic detection method.
    Tallen G; Fehr S; Saeger W; Uhlig H; Lüdecke DK
    Acta Endocrinol (Copenh); 1993 May; 128(5):411-7. PubMed ID: 8317187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels.
    Greenman Y; Tordjman K; Stern N
    Clin Endocrinol (Oxf); 1998 May; 48(5):547-53. PubMed ID: 9666865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.
    Hamrahian AH; Yuen KC; Gordon MB; Pulaski-Liebert KJ; Bena J; Biller BM
    Pituitary; 2016 Jun; 19(3):332-41. PubMed ID: 26897383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A; Ferone D; Lombardi G; Lastoria S
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
    Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey.
    Karaca Z; Yarman S; Ozbas I; Kadioglu P; Akturk M; Kilicli F; Dokmetas HS; Colak R; Atmaca H; Canturk Z; Altuntas Y; Ozbey N; Hatipoglu N; Tanriverdi F; Unluhizarci K; Kelestimur F
    J Endocrinol Invest; 2018 Jan; 41(1):129-141. PubMed ID: 28634705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?
    Perić B; Kruljac I; Šundalić S; Pećina HI; Jović A; Štefanović M; Butorac D; Vrkljan M
    Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct dopaminergic personality patterns in patients with prolactinomas: a comparison with nonfunctioning pituitary adenoma patients and age- and gender-matched controls.
    Athanasoulia AP; Ising M; Pfister H; Mantzoros CS; Stalla GK; Sievers C
    Neuroendocrinology; 2012; 96(3):204-11. PubMed ID: 22343218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.
    Lloyd RV; Cano M; Chandler WF; Barkan AL; Horvath E; Kovacs K
    Am J Pathol; 1989 Mar; 134(3):605-13. PubMed ID: 2466405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.